Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 16, 2015
Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68
Chuangyan Zhai, Dominik Summer, Christine Rangger, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 16, 2019
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. <i>Pharmaceuticals</i> 2019, <i>12</i>, 13
Maximilian Klingler, Christine Rangger, Dominik Summer, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 18, 2019
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
Maximilian Klingler, Christine Rangger, Dominik Summer, et al.
Scientific Reports
|
September 24, 2020
Live-cell imaging with Aspergillus fumigatus-specific fluorescent siderophore conjugates
Joachim Pfister, Alexander Lichius, Dominik Summer, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 14, 2018
Pretargeted Imaging with Gallium-68-Improving the Binding Capability by Increasing the Number of Tetrazine Motifs
Dominik Summer, Sonja Mayr, Milos Petrik, et al.
Theranostics
|
June 14, 2018
Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
Maximilian Klingler, Clemens Decristoforo, Christine Rangger, et al.
Theranostics
|
August 2, 2019
Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum
Maximilian Klingler, Clemens Decristoforo, Christine Rangger, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 19, 2016
Targeting Gastrointestinal Stromal Tumor with <sup>68</sup>Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines
Achim Paulmichl, Dominik Summer, Claudia Manzl, et al.
Molecular Imaging and Biology
|
February 25, 2016
Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors
Chuangyan Zhai, Gerben M Franssen, Milos Petrik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 12, 2018
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
Maximilian Klingler, Dominik Summer, Christine Rangger, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 16, 2015
Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68
Chuangyan Zhai, Dominik Summer, Christine Rangger, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 16, 2019
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. <i>Pharmaceuticals</i> 2019, <i>12</i>, 13
Maximilian Klingler, Christine Rangger, Dominik Summer, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 18, 2019
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
Maximilian Klingler, Christine Rangger, Dominik Summer, et al.
Scientific Reports
|
September 24, 2020
Live-cell imaging with Aspergillus fumigatus-specific fluorescent siderophore conjugates
Joachim Pfister, Alexander Lichius, Dominik Summer, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 14, 2018
Pretargeted Imaging with Gallium-68-Improving the Binding Capability by Increasing the Number of Tetrazine Motifs
Dominik Summer, Sonja Mayr, Milos Petrik, et al.
Theranostics
|
June 14, 2018
Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
Maximilian Klingler, Clemens Decristoforo, Christine Rangger, et al.
Theranostics
|
August 2, 2019
Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum
Maximilian Klingler, Clemens Decristoforo, Christine Rangger, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 19, 2016
Targeting Gastrointestinal Stromal Tumor with <sup>68</sup>Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines
Achim Paulmichl, Dominik Summer, Claudia Manzl, et al.
Molecular Imaging and Biology
|
February 25, 2016
Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors
Chuangyan Zhai, Gerben M Franssen, Milos Petrik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 12, 2018
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
Maximilian Klingler, Dominik Summer, Christine Rangger, et al.
Page
of 3